A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe.
Phase of Trial: Phase II/III
Latest Information Update: 07 Nov 2014
At a glance
- Drugs Lamivudine/abacavir (Primary) ; Lamivudine/zidovudine/abacavir (Primary) ; Lopinavir/ritonavir (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 29 Oct 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 07 Feb 2009 New trial record